TipHub

₹714.65

▼ -6.34 -0.88%

As of 27 Jul 2026 · delayed

NSE Listed

Remus Pharmaceuticals Limited (REMUS)

Volume: 2,200Avg Vol 1W: 1,620Avg Vol 1M: 4,98052W Range:₹580₹978.65
NSE BSE www.remuspharma.com AI Report
Key Ratios
Checked 1d ago
Market Cap₹2,252 Cr
Current Price₹714.65
Previous Close₹720.99
High / Low (52w)₹978.65 / ₹580
Volume2,200
Avg Vol (1W)1,620
Avg Vol (1M)4,980
Stock P/E34.33
Book Value₹276.4
Dividend Yield—
ROE—
ROA—
Revenue (TTM)₹625 Cr
Revenue Growth191.3%
Profit Margin—
Total Debt₹3 Cr
Shares Outstanding—
Face Value—
EPS (TTM)₹20.97
P/B2.6
Debt / Equity—
50 DMA₹746.61
200 DMA₹706.47
Day change-0.88%
Price Chart
₹714.65▼ 24.77% · 1Y
₹950₹58376K
2025-07-29
2026-07-27

20-day avg volume: 5K shares

Cons
  • Revenue fell 34% YoY.
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹13 Cr₹19 Cr₹25 Cr₹47 Cr₹218 Cr₹625 Cr
EBITDA₹1 Cr₹1 Cr₹5 Cr₹12 Cr₹32 Cr₹49 Cr
Net Profit₹1 Cr₹1 Cr₹3 Cr₹9 Cr₹22 Cr₹29 Cr
EPS8.1210.634.3483.24152.0165.21
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹5 Cr₹11 Cr₹16 Cr₹35 Cr₹257 Cr₹433 Cr
Total Liabilities₹3 Cr₹8 Cr₹9 Cr₹16 Cr₹153 Cr₹150 Cr
Equity₹2 Cr₹3 Cr₹7 Cr₹19 Cr₹104 Cr₹283 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹7 Cr——
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹6 Cr₹8 Cr₹10 Cr₹14 Cr
Investing₹0 Cr₹-5 Cr₹-15 Cr₹-9 Cr₹-11 Cr
Financing₹0 Cr₹0 Cr₹12 Cr₹24 Cr₹6 Cr
Free Cash Flow₹0 Cr₹6 Cr₹8 Cr₹10 Cr₹14 Cr
Shareholding
Promoter 70.95% Institutions 6.11% Public 22.93%
Efficiency & Working Capital
ROCE21.6%
Interest Coverage33.4
Dividend Payout—
Debtor Days64 d
Inventory Days30 d
Payable Days42 d
Cash Conversion Cycle52 d
Working Capital Days94 d
Shareholding Details

As of 2026-03-31

Promoter71%
FII5.3%
DII0.8%
Institutions6.1%
Public22.9%
Promoter Pledge0%
No. of Shareholders2,009
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2023May 2023May 2023Sept 2023Mar 2024Jun 2024Sept 2024Mar 2025Jul 2025Jul 2025Sept 2025Mar 2026
Promoters92.8%68.4%68.4%69.6%70.6%70.7%70.8%70.9%70.9%70.9%70.9%71%
FIIs0%2.5%2.5%2.4%3.2%3%3.2%4.8%5%5%5%5.3%
DIIs0%3.1%0.9%0%0%0%0%0%0.8%0%0%0.8%
Public7.2%26%28.2%28%26.2%26.3%26%24.4%23.3%24.1%24.1%22.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders301,7431,7438561,1241,5771,7533982,0172,0172,0322,009
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Shah Arpit DeepakkumarShareholding of Promoter and Promoter Group17.7%20,81,200
Roma Vinodbhai ShahShareholding of Promoter and Promoter Group17.2%20,27,800
Anar Swapnil ShahShareholding of Promoter and Promoter Group17%20,00,000
Swapnil Jatinbhai ShahShareholding of Promoter and Promoter Group17%20,00,000
India Emerging Giants Fund LimitedPublic Shareholding4.9%5,73,600
Rekha Gunavanth KumarPublic Shareholding1.1%1,28,000
Hemant Ishwarlal ModiShareholding of Promoter and Promoter Group1%1,17,600
Renosen Pharmaceuticals Private LimitedShareholding of Promoter and Promoter Group0.9%1,08,500
Mansi Aadarsh ShahShareholding of Promoter and Promoter Group0.1%8,000
Sonal Hemantbhai ModiShareholding of Promoter and Promoter Group0.1%8,000
Vinodkumar Gandalal ShahShareholding of Promoter and Promoter Group0.1%6,800
Alkaben Dipakkumar ShahShareholding of Promoter and Promoter Group0%2,600
Dhruvalben Vishal ShahShareholding of Promoter and Promoter Group0%700
Deepak ShahShareholding of Promoter and Promoter Group0%0
Chetnaben Vinodkumar ShahShareholding of Promoter and Promoter Group0%0
Hemali VakaniShareholding of Promoter and Promoter Group0%0
Jatin Siddharthbhai ShahShareholding of Promoter and Promoter Group0%0
Pinkyben Jatinbhai ShahShareholding of Promoter and Promoter Group0%0
Athena Arpit ShahShareholding of Promoter and Promoter Group0%0
Vihaan Swapnil ShahShareholding of Promoter and Promoter Group0%0
Suhana Swapnil ShahShareholding of Promoter and Promoter Group0%0
Modi Hemantbhai Ishwarlal HufShareholding of Promoter and Promoter Group0%0
Jatin Siddharthabhai Shah HufShareholding of Promoter and Promoter Group0%0
Swapnil J Shah HufShareholding of Promoter and Promoter Group0%0
Shah Vinodkumar Gandalal HufShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
SWAPNIL JATINBHAI SHAHChairman(Non Exe)&Dir(Non-Ind)2025
ARPIT DEEPAKKUMAR SHAHManaging Director2025
Roma Vinodbhai ShahWhole-time Director2025
Anar Swapnil ShahNon-Exec & Non-Independent Dir2025
Vishrut Chandramauli PathakIndependent Non Exe. Director2025
Balwant PurohitIndependent Non Exe. Director2025
Sanjana Sanjeev ShahIndependent Non Exe. Director2025
Deval PatelCompany Sec. & Compli. Officer2025
Segments — Geography
RegionRevenueShare
Export₹5 Cr6.2%
Domestic₹74 Cr93.8%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹101366
Corporate Actions
TypeDateValueRemark
dividend2025-11-14₹0.5 (5%)Interim 1
dividend2025-09-18₹0.5 (5%)Final
bonus2025-07-041:11:1 Bonus Issue of Equity Shares
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202520061725
2025100057
202500061116
Company Information
Incorporated2015
ChairmanSWAPNIL JATINBHAI SHAH
AuditorPankaj R Shah & Associates
Investor Email[email protected]
🌐 www.remuspharma.com ↗

📍 1101 to 1103 South Tower One42, B/H Ashok Vatika Amblibopal Rd, Ahmedabad, Gujarat, 380054

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Reliable Data Service Ltd.Reliance Industries Ltd.Religare Enterprises Ltd.Reliance Infrastructure Ltd.Ravindra Energy LimitedRemsons Industries Ltd.Shree Renuka Sugars Ltd.Repco Home Finance Ltd.Rudrabhishek Enterprises Ltd.Repro India LimitedResponsive Industries Ltd.JHS Svendgaard Retail Ventures Ltd.All “R” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search